These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 2123236)

  • 21. Evoked potentials in chronic inflammatory demyelinating polyneuropathy.
    Pakalnis A; Drake ME; Barohn RJ; Chakeres DW; Mendell JR
    Arch Neurol; 1988 Sep; 45(9):1014-6. PubMed ID: 2843153
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Magnetic resonance imaging findings in chronic inflammatory demyelinating polyneuropathy with intracranial findings and enhancing, thickened cranial and spinal nerves.
    Kale HA; Sklar E
    Australas Radiol; 2007 Oct; 51 Spec No.():B21-4. PubMed ID: 17875147
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mixed connective tissue disease associated with chronic inflammatory demyelinating polyneuropathy.
    Luostarinen L; Himanen SL; Pirttilä T; Molnar G
    Scand J Rheumatol; 1999; 28(5):328-30. PubMed ID: 10568432
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chronic inflammatory demyelinating polyneuropathy with multiple hypertrophic nerves in intracranial, and intra- and extra-spinal segments.
    Niino M; Tsuji S; Tashiro K
    Intern Med; 1999 May; 38(5):445-9. PubMed ID: 10397086
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Central lesions in chronic inflammatory demyelinating polyneuropathy: an MRI study.
    Feasby TE; Hahn AF; Koopman WJ; Lee DH
    Neurology; 1990 Mar; 40(3 Pt 1):476-8. PubMed ID: 2314591
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anti-beta-tubulin antibodies have no diagnostic value in patients with chronic inflammatory demyelinating polyneuropathy.
    van Schaik IN; Vermeulen M; van Doorn PA; Brand A
    J Neurol; 1995 Sep; 242(9):599-603. PubMed ID: 8551323
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recurrent Isolated Sixth Nerve Palsy in Relapsing-Remitting Chronic Inflammatory Demyelinating Polyneuropathy.
    Al-Bustani N; Weiss MD
    J Clin Neuromuscul Dis; 2015 Sep; 17(1):18-21. PubMed ID: 26301375
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Chronic inflammatory demyelinating polyneuropathies].
    Ponomareva EN; Antonov IP; Ponomarev VV
    Zh Nevrol Psikhiatr Im S S Korsakova; 1996; 96(4):22-5. PubMed ID: 9281271
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [A method for determining kappa-lambda quotients of immunoglobulins].
    Jahn D; Domke K
    Z Med Lab Diagn; 1987; 28(4):225-7. PubMed ID: 3114974
    [No Abstract]   [Full Text] [Related]  

  • 30. Delayed appearance of anti-myelin-associated glycoprotein antibodies in a patient with chronic demyelinating polyneuropathy.
    Valldeoriola F; Graus F; Steck AJ; Muñoz E; de la Fuente M; Gallart T; Ribalta T; Bombí JA; Tolosa E
    Ann Neurol; 1993 Sep; 34(3):394-6. PubMed ID: 7689821
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Frequency of central lesions in polyneuropathy associated with IgM monoclonal gammopathy: an MRI, neurophysiological and immunochemical study.
    Léger JM; Younes-Chennoufi AB; Zuber M; Bouche P; Jauberteau MO; Dormont D; Danon F; Baumann N; Brunet P
    J Neurol Neurosurg Psychiatry; 1992 Feb; 55(2):112-5. PubMed ID: 1538215
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CNS involvement in chronic inflammatory demyelinating polyneuropathy: an electrophysiological and MRI study.
    Uncini A; Gallucci M; Lugaresi A; Porrini AM; Onofrj M; Gambi D
    Electromyogr Clin Neurophysiol; 1991 Sep; 31(6):365-71. PubMed ID: 1935761
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Inflammatory demyelinating chronic polyneuropathy: a contribution to the characterization of the disease].
    Cabrera-Lima AV; Estrada R; Santiago-Luis R; Alfaro I; González A; Galarraga-Inza J
    Rev Neurol; 1999 Apr 16-30; 28(8):772-8. PubMed ID: 10363320
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CNS involvement in Japanese patients with chronic inflammatory demyelinating polyradiculoneuropathy.
    Ohtake T; Komori T; Hirose K; Tanabe H
    Acta Neurol Scand; 1990 Feb; 81(2):108-12. PubMed ID: 2327229
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MRI of enlarged dorsal ganglia, lumbar nerve roots, and cranial nerves in polyradiculoneuropathies.
    Castillo M; Mukherji SK
    Neuroradiology; 1996 Aug; 38(6):516-20. PubMed ID: 8880708
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Does the chronic inflammatory demyelinating polyradiculoneuropathy due to secondary cause differ from primary?
    Wadwekar V; Kalita J; Misra UK
    Neurol India; 2011; 59(5):664-8. PubMed ID: 22019647
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sural nerve T cells in demyelinating polyneuropathy associated with monoclonal gammopathy.
    Eurelings M; Notermans NC; Wokke JH; Bosboom WM; Van den Berg LH
    Acta Neuropathol; 2002 Feb; 103(2):107-14. PubMed ID: 11810175
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fiber density in acute and chronic inflammatory demyelinating polyneuropathy.
    Gantayat M; Swash M; Schwartz MS
    Muscle Nerve; 1992 Feb; 15(2):168-71. PubMed ID: 1549137
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Chronic inflammatory demyelinating polyneuropathy (CIDP)].
    Tanaka H; Baba M
    Ryoikibetsu Shokogun Shirizu; 1999; (27 Pt 2):479-82. PubMed ID: 10434704
    [No Abstract]   [Full Text] [Related]  

  • 40. Myopathy associated with monoclonal gammopathy and leukoencephalopathy.
    Schluep M; Regli F
    Schweiz Arch Neurol Psychiatr (1985); 1992; 143(6):553-9. PubMed ID: 1283033
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.